The transition to value-based payment models represents a major shift for U.S. healthcare providers. Under traditional volume-based care, health systems are accustomed to looking at patient outcomes, ...

Healthcare analytics company Milliman MedInsight’s methodologies and analytics will be integrated into Epic’s new Value-Based Performance Management module. Epic Value-Based Performance Management ...

The goal in shifting from paying for volume to value-based care is simple: to align payers and healthcare providers around high-quality care that improves outcomes and lowers cost. Operationalizing ...

It's still early days for value-based care. The VBC landscape today is characterized by widespread but sometimes superficial adoption. While many health systems have initiated value-based care ...

SEATTLE, Sept. 14, 2022 /PRNewswire/ -- Milliman MedInsight announces a new strategic relationship with Epic, the most widely-used electronic health records system in the U.S., to offer advanced ...

Revenue tied to value-based care contracts is growing. The latest data reveal that 14% of U.S. provider reimbursement is tied to capitated risk models, compared to only 7% three years ago. At the same ...

Value-based care prioritizes patient outcomes and cost reduction, requiring alignment of reimbursement models and financial sustainability management. Private insurers are reforming payment models, ...

Health care practitioners and leaders share a common goal to provide exceptional care for patients. The Quadruple Aim framework for health systems encompasses reducing costs, improving population ...

Gettysburg, PA, Feb. 20, 2018 (GLOBE NEWSWIRE) -- After expanding the event into a week-long series consisting of several seminars, summits, and workshops, OPEN MINDS wrapped up its 2018 OPEN MINDS ...

Tampa-based Orthopaedic Solutions Management (OSM), one of the country’s largest orthopedic-focused management services organizations, is at the forefront of this in Florida after more than eight ...

Policy makers and health plans seek value-based management of specialty drugs. This study examines real-world factors that favor some approaches over others and their potential impact. Objectives: ...